Literature DB >> 12458905

Overview of immune system development in the dog: comparison with humans.

P J Felsburg1.   

Abstract

Dogs play an important role in toxicology because of their importance as a large animal, pre-clinical model for evaluating potential toxicity in human drug development including the effects of investigational drugs on the immune system. The purpose of this paper is to review the development of the canine immune system during the fetal, neonatal and postnatal periods and to compare it with that of the human immune system. Unlike rodents, the development of the canine immune system shares many similarities to that of the human. In both dogs and humans, the immune system, including the mucosal immune system, is fully developed before birth although the maturity of the immune response may continue into the postnatal period.

Entities:  

Mesh:

Year:  2002        PMID: 12458905     DOI: 10.1191/0960327102ht286oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  33 in total

1.  Glucose transporter-4 in white blood cells of young and old sled dogs: a model for human biomarker development.

Authors:  Theresia M Schnurr; Arleigh J Reynolds; Lawrence K Duffy; Kriya L Dunlap
Journal:  Polar Rec (Gr Brit)       Date:  2013-11-28       Impact factor: 0.658

2.  Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator.

Authors:  Ruolin Lu; Chad Groer; Peter A Kleindl; K Ryan Moulder; Aric Huang; Jordan R Hunt; Shuang Cai; Daniel J Aires; Cory Berkland; M Laird Forrest
Journal:  J Control Release       Date:  2019-06-04       Impact factor: 9.776

Review 3.  Animal Models for Stem Cell-Based Pulp Regeneration: Foundation for Human Clinical Applications.

Authors:  Misako Nakashima; Koichiro Iohara; Marco C Bottino; Ashraf F Fouad; Jacques E Nör; George T-J Huang
Journal:  Tissue Eng Part B Rev       Date:  2019-01-09       Impact factor: 6.389

4.  Humoral immunity to AAV-6, 8, and 9 in normal and dystrophic dogs.

Authors:  Jin-Hong Shin; Yongping Yue; Bruce Smith; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2012-01-11       Impact factor: 5.695

Review 5.  Modeling opportunities in comparative oncology for drug development.

Authors:  Ira K Gordon; Chand Khanna
Journal:  ILAR J       Date:  2010

6.  Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.

Authors:  Arta M Monjazeb; Michael S Kent; Steven K Grossenbacher; Christine Mall; Anthony E Zamora; Annie Mirsoian; Mingyi Chen; Amir Kol; Stephen L Shiao; Abhinav Reddy; Julian R Perks; William T N Culp; Ellen E Sparger; Robert J Canter; Gail D Sckisel; William J Murphy
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 12.531

7.  Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model.

Authors:  Monica S Thakar; Xiao-Bing Zhang; Brian C Beard; George E Sale; Erlinda B Santos; Laura Peterson; Hans-Peter Kiem; Brenda M Sandmaier
Journal:  Exp Hematol       Date:  2009-07-17       Impact factor: 3.084

8.  Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.

Authors:  William H Peranteau; Todd E Heaton; Yu-Chen Gu; Susan W Volk; Thomas R Bauer; Keith Alcorn; Laura M Tuschong; Mark P Johnson; Dennis D Hickstein; Alan W Flake
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

9.  Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I.

Authors:  E Kakkis; T Lester; R Yang; C Tanaka; V Anand; J Lemontt; M Peinovich; M Passage
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

10.  Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.

Authors:  Eric C Ledbetter; James J Mun; David Kowbel; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.